Multiple Sclerosis and Related Disorders, 3(3), 355-363. Elsevier Khatri, B O, Pelletier, J, Kappos, L, Hartung, H P, Comi, G, Barkhof, F, von Rosenstiel, P, Meng, X, Grinspan, A, Hashmonay, R & Cohen, J A 2014, ' Effect of prior treatment status and reasons for discontinuation on the efficacy and safety of fingolimod vs. interferon β-1a intramuscular: Subgroup analyses of the Trial Assessing Injectable Interferon vs. Fingolimod Oral in Relapsing–Remitting Multiple Sclerosis (TRANSFORMS) ', Multiple Sclerosis and Related Disorders, vol. 3, no. 3, pp. 355-363 . https://doi.org/10.1016/j.msard.2013.11.006